Publications by authors named "Peter Howarth"

Claim this Profile
I
Impact of Demographics on Mepolizumab Effectiveness in Severe Asthma: One-Year REALITI-A Subanalysis.
Geoffrey Chupp, Liam G Heaney, Girolamo Pelaia, Carlos Almonacid, Aoife Maxwell, Peter Howarth

J Allergy Clin Immunol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study.
Giorgio Walter Canonica, Arnaud Bourdin, Erika Penz, Lingjiao Zhang, Peter Howarth

J Asthma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two years.
Giorgio W Canonica, Diego Bagnasco, Jason K Lee, Geoffrey Chupp, Florence Schleich, Peter Howarth

ERJ Open Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.
P Jane McDowell, Adnan Azim, John Busby, Sarah Diver, Freda Yang, Peter Howarth

J Allergy Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: a subgroup analysis of the MARS study.
Tomonori Ishii, Hideaki Kunishige, Mitsuhiro Yoshida, Etsuko Hayashi, Masaki Komatsubara, Peter Howarth

Mod Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Categorizing clinical response to mepolizumab for patients with chronic rhinosinusitis with nasal polyps: SYNAPSE trial.
Claire Hopkins, Larry Borish, Jared Silver, Peter Howarth, Robert Chan

Ann Allergy Asthma Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial profiling reveals complex cellular responses of anti-IL5 treatment with mepolizumab in eosinophilic chronic rhinosinusitis with nasal polyposis.
Nicholas P West, Sarah M Williams, James Sinclair, Peter Howarth, Peter K Smith

J Leukoc Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
Jason K Lee, Stephen J Pollard, Mark C Liu, Florence Schleich, Girolamo Pelaia, Peter Howarth

Ann Allergy Asthma Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient perspectives on the use of oral corticosteroids in asthma.
Tonya Winders, Monica Fletcher, John Oppenheimer, Peter Howarth, Zeina Eid Antoun

J Asthma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma in the Biologics Era: Should Oral Corticosteroid Therapy Be Relegated to History?
Florence Schleich, John J Oppenheimer, Guy Brusselle, Liam G Heaney, William W Busse, Peter Howarth

J Allergy Clin Immunol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of mepolizumab for patients with bronchial asthma in routine clinical practice in Japan - final report of special drug use investigation.
Eriko Tsuboi, Hironobu Aoki, Kiyomi Aizawa, Masaki Komatsubara, Peter Howarth

Respir Investig· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial.
Ruchong Chen, Yuanrong Dai, Danrong Yang, Chuntao Liu, Wei Han, Peter Howarth

Allergy Asthma Immunol Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis.
Danilo Di Bona, Giovanni Paoletti, Palma Carlucci, Federico Spataro, Stephen Weng, Peter Howarth

J Asthma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: Long-term observation of the MARS study.
Tomonori Ishii, Hideaki Kunishige, Tamami Kobayashi, Etsuko Hayashi, Masaki Komatsubara, Peter Howarth

Mod Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the Blood Cytokine Profile in Asthma to Understand Asthma Heterogeneity.
Karina Bingham, Yousef Al Zahrani, Iain Stewart, Michael A Portelli, Andrew Fogarty, Peter H Howarth

Immun Inflamm Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A RESPONSE to antiIL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocol.
Petros Bakakos, Isam Alobid, Jannis Constantinidis, Peter Hellings, Oliver Pfaar, Peter Howarth

J Allergy Clin Immunol Glob· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
David J Jackson, Michael E Wechsler, Daniel J Jackson, David Bernstein, Stephanie Korn, Peter Howarth

N Engl J Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study.
Ian Pavord, Robert Chan, Nicola Brown, Peter Howarth, Martyn Gilson

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED.
Roy Meys, Frits M E Franssen, Alex J Van 't Hul, Per S Bakke, Massimo Caruso, Peter H Howarth

Health Qual Life Outcomes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics.
Nazanin Zounemat Kermani, Kian Fan Chung, Giuseppe Macis, Giuseppe Santini, Franz A A Clemeno, Peter Howarth

Eur Respir J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special issue on pupil function: trends and advances in technology and understanding and proceedings of the 34th international pupil colloquium, L V Prasad eye institute, Hyderabad, India.
Shrikant R Bharadwaj, Peter Howarth

Doc Ophthalmol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils.
Kathleen M Buchheit, Dominick Shaw, Geoffrey Chupp, Lauri Lehtimaki, Enrico Heffler, Peter H Howarth

Allergy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-Optimal Disease Control and Low Blood Eosinophil Testing Frequency in Chinese Adult Patients with Asthma Receiving GINA Step 4/5 Treatment: A Real-World Study.
Victoria S Benson, James Siddall, Adam Haq, Mark Small, Zhiliu Tang, Peter Howarth

J Asthma Allergy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host-microbial interactions differ with age of asthma onset.
Ali Versi, Adnan Azim, Fransiskus Xaverius Ivan, Mahmoud I Abdel-Aziz, Stewart Bates, Peter Howarth

Eur Respir J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Burden, Treatment Patterns and Asthma Control in Adult Patients with Asthma in China: A Real-World Study.
Victoria S Benson, James Siddall, Adam Haq, Mark Small, Rafael Alfonso-Cristancho, Peter Howarth

J Asthma Allergy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis